Encapsulation into PEG-Liposomes Does Not Improve the Bioavailability of Pulmonary Delivered Salmon Calcitonin
Autor: | Janani Swaminathan, Carsten Ehrhardt, Oliviero L. Gobbo, Anne Marie Healy, Frederic Tewes |
---|---|
Přispěvatelé: | School of Pharmacy and Pharmaceutical Sciences and Institute of Neuroscience, Trinity College Dublin, Ingénierie de la vectorisation particulaire, Université d'Angers (UA)-Institut National de la Santé et de la Recherche Médicale (INSERM), Pharmacologie des anti-infectieux (PHAR), Université de Poitiers-Institut National de la Santé et de la Recherche Médicale (INSERM), School of Pharmacy and Pharmaceutical Science [Dublin, Irlande], School of Pharmacy and Pharmaceutical Science |
Rok vydání: | 2014 |
Předmět: |
Calcitonin
Male Pulmonary and Respiratory Medicine Surface Properties Chemistry Pharmaceutical Biological Availability Pharmaceutical Science Breast Neoplasms 02 engineering and technology Buffers Pharmacology 030226 pharmacology & pharmacy Polyethylene Glycols 03 medical and health sciences 0302 clinical medicine Pharmacokinetics Cell Line Tumor Administration Inhalation Animals Pharmacology (medical) Particle Size Rats Wistar Lung ComputingMilieux_MISCELLANEOUS Aerosolization Drug Carriers Liposome Bone Density Conservation Agents Inhalation Chemistry Nebulizers and Vaporizers Vesicle [SDV.SP]Life Sciences [q-bio]/Pharmaceutical sciences Hydrogen-Ion Concentration 021001 nanoscience & nanotechnology Controlled release Rats 3. Good health Bioavailability [SDV.MP]Life Sciences [q-bio]/Microbiology and Parasitology Area Under Curve Delayed-Action Preparations Injections Intravenous Liposomes Female Stress Mechanical 0210 nano-technology Drug carrier |
Zdroj: | JOURNAL OF AEROSOL MEDICINE AND PULMONARY DRUG DELIVERY JOURNAL OF AEROSOL MEDICINE AND PULMONARY DRUG DELIVERY, 2014, 27 (1), pp.1-11. ⟨10.1089/jamp.2013.1049⟩ |
ISSN: | 1941-2703 1941-2711 |
DOI: | 10.1089/jamp.2013.1049 |
Popis: | Salmon calcitonin (sCT) is approved for the short-term treatment of Paget's disease and hypercalcemia. As pulmonary delivery might improve the drug's efficacy, a variety of liposomal sCT formulations for inhalation were prepared and characterized with the intention of developing a controlled release formulation.The influence of pH of the loading buffer, charge of the vesicular surface, and membrane rigidity on particle size, ζ-potential, and sCT encapsulation efficiency of formulations was studied. The most promising systems were investigated for their ability to withstand nebulization stresses using an Aeroneb(®) vibrating mesh device. In vitro studies were carried out to determine sCT release from the vesicles and the bioactivity of the peptide post nebulization. Lastly, pharmacokinetics of sCT liposomes following intratracheal aerosolization in an experimental rat model were investigated and compared with intravenous injection.Liposomes prepared with acidic loading buffer and comprising rigid lipid membranes showed an optimal compromise between small particle size, high encapsulation efficiency, and sCT stability. Polyethylene glycol (PEG) liposomes showed the highest encapsulation efficiency overall, regardless of the ζ-potential of the vesicles. Positive surface charge, however, yielded higher entrapment in non-PEGylated liposomes. All liposomes tested were stable during nebulization. The bioactivity of sCT after formulation into liposomes was 52-55%. Intratracheal nebulization in rats revealed that the bioavailability and other pharmacokinetic parameters were not enhanced by liposomes, when compared with sCT solution. Following intravenous administration, however, liposomes showed significantly higher bioavailability and AUCinf (area under the curve to the infinity time point) than controls.The developed liposomal formulations were not optimal carriers for pulmonary delivery of sCT. Due to the low amounts of peptide released from the vesicles, enzymatic digestion by peptidases in the airspace reduced the bioavailability significantly. Liposomal encapsulation of sCT, nevertheless, resulted in improved pharmacokinetics following injection. |
Databáze: | OpenAIRE |
Externí odkaz: |